Zosano Pharma Corporation (NASDAQ:ZSAN) went up to recover about 362.59% since recording its record low price of $3.61. The stock experienced 8.51% jump, arriving at $16.7 on 03/13/2018. During the day, the stock price traveled from $13.62 to $18.429. This company shares are 379.04% off its target price of $80 and the current market capitalization stands at $35.4M. The recent change has given its price a 101.58% lead over SMA 50 and -64.01% deficit over its 52-week high. The stock witnessed 314.39% gains, 43.74% gains and -6.18% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ZSAN’s volatility during a week at 56.77% and during a month it has been found around 37.77%.Zosano Pharma Corporation (ZSAN) Top Holders
Institutional investors currently hold around $3 million or 21% in ZSAN stock. Look at its top three institutional owners. Vanguard Group Inc owns $762 thousand in Zosano Pharma Corporation, which represents roughly 2.15% of the company’s market cap and approximately 25.4% of the institutional ownership. Similar statistics are true for the second largest owner, Perceptive Advisors Llc, which owns 25,000 shares of the stock are valued at $385 thousand. The third largest holder is Victory Capital Management Inc, which currently holds $198 thousand worth of this stock and that ownership represents nearly 0.56% of its market capitalization.
At the end of 12/31/2017 reporting period, 10 institutional holders increased their position in Zosano Pharma Corporation (NASDAQ:ZSAN) by some 30,649 shares, 11 decreased positions by 248,313 and 8 held positions by -108,353. That puts total institutional holdings at 170,609 shares, according to SEC filings. The stock grabbed 4 new institutional investments totaling 19,361 shares while 9 institutional investors sold out their entire positions totaling 232,576 shares.Zosano Pharma Corporation (NASDAQ:ZSAN) Insider Trades
Multiple company employees have indulged in significant insider trading. Zosano Pharma Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Amzak Capital Management, Llc has sold 88,281 shares of Zosano Pharma Corporation (ZSAN) in trading session dated Feb. 27, 2018. These shares are worth $741,560 and were traded at $8.4 each. The SEC filing shows that Greathouse Kenneth performed a purchase of 55,000 shares. The Director added these shares by way of transaction on Dec. 06, 2017. The company’s shares were assimilated at $0.61 per share worth to an investment of some $33,550 on account of Greathouse Kenneth.
Director, Greathouse Kenneth, purchased 95,000 common shares of Zosano Pharma Corporation (ZSAN) in the open market. In a transaction dated Dec. 01, 2017, the shares were bought at an average price of $0.62, giving away a sum of $58,900. After this purchase, 145,000 common shares of ZSAN are directly owned by the insider, with total stake valued at $2,421,500.
In the transaction dated Nov. 15, 2017, the great number of shares acquired came courtesy the Director; Greathouse Kenneth added a total of 50,000 shares at an average price of $0.62, amounting to approximately $31,000. The insider now directly owns 50,000 shares worth $835,000.Zosano Pharma Corporation (ZSAN) Analyst Guide
Not many analysts have released their opinion on Zosano Pharma Corporation (NASDAQ:ZSAN), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.